A Phase 2 Study of Dasatinib, Prednisone, and Blinatumomab for Older Patients with Philadelphia-Chromosome (Ph) Positive or Ph-like Acute Lymphoblastic Leukemia (ALL) (with Dasatinib Sensitive Fusions/ Mutations)
Year: 2021
Type: conference-abstract
Source: Blood
Institutions: Cleveland Clinic, Fred Hutch Cancer Center, University of Rochester Medicine, Children's Hospital Los Angeles, Memorial Sloan Kettering Cancer Center, OU Health Stephenson Cancer Center, University of Oklahoma Health Sciences Center, University of California, Irvine, University of California, Irvine Medical Center, University of Southern California, Medical College of Wisconsin, University of Rochester, Mayo Clinic, Dana-Farber Cancer Institute, National Cancer Institute, Duke University
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3214726543